8,750 Waters Corporation $WAT Shares Acquired by Robeco Institutional Asset Management B.V.

Robeco Institutional Asset Management B.V. increased its holdings in shares of Waters Corporation (NYSE:WAT) by 16.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 61,273 shares of the medical instruments supplier’s stock after acquiring an additional 8,750 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.06% of Waters worth $26,923,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Pilgrim Global Advisors LLC purchased a new stake in Waters in the second quarter worth $466,131,171,000. BlackRock Inc. purchased a new stake in Waters during the second quarter valued at about $3,182,191,000. State Street Corp lifted its stake in shares of Waters by 0.5% during the 2nd quarter. State Street Corp now owns 4,382,008 shares of the medical instruments supplier’s stock valued at $1,643,428,000 after buying an additional 19,998 shares in the last quarter. Jupiter Topco LLC purchased a new stake in shares of Waters during the second quarter worth $623,921,000. Finally, Wellington Management Group LLP boosted its holdings in shares of Waters by 69.2% in the second quarter. Wellington Management Group LLP now owns 1,373,150 shares of the medical instruments supplier’s stock worth $514,986,000 after acquiring an additional 561,824 shares during the period. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Insider Transactions at Waters

In other news, Director Christopher Kuebler sold 3,626 shares of the firm’s stock in a transaction dated Thursday, August 6th. The shares were sold at an average price of $397.94, for a total transaction of $1,442,930.44. Following the sale, the director owned 17,808 shares of the company’s stock, valued at $7,086,515.52. This trade represents a 16.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.31% of the company’s stock.

Waters Stock Down 0.5%

WAT stock opened at $453.42 on Friday. The stock has a market capitalization of $44.55 billion, a P/E ratio of 113.07, a P/E/G ratio of 2.65 and a beta of 1.15. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.86 and a quick ratio of 1.29. Waters Corporation has a 1-year low of $282.77 and a 1-year high of $465.36. The business has a fifty day moving average price of $424.37 and a 200-day moving average price of $381.40.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, August 4th. The medical instruments supplier reported $3.05 EPS for the quarter, beating the consensus estimate of $3.01 by $0.04. Waters had a return on equity of 11.27% and a net margin of 3.58%. The company had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.62 billion. During the same period last year, the firm posted $2.95 earnings per share. Waters’s revenue was up 113.3% compared to the same quarter last year. Waters has set its Q3 2026 guidance at 3.950-4.050 EPS and its FY 2026 guidance at 14.450-14.650 EPS. Equities analysts forecast that Waters Corporation will post 14.56 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on WAT. Sanford C. Bernstein began coverage on shares of Waters in a research report on Friday, June 26th. They issued an “outperform” rating and a $435.00 price objective for the company. UBS Group upgraded Waters from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $375.00 to $490.00 in a research report on Wednesday, September 9th. Wall Street Zen downgraded Waters from a “buy” rating to a “hold” rating in a report on Sunday, October 18th. Stifel Nicolaus set a $420.00 price target on Waters in a research note on Wednesday, August 5th. Finally, Guggenheim boosted their price target on Waters from $440.00 to $490.00 and gave the stock a “buy” rating in a research report on Thursday, October 1st. Two investment analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $443.79.

About Waters

Waters Corporation (NYSE:WAT) develops and manufactures analytical technologies used to measure, identify and characterize chemical and biological substances. Its customers include pharmaceutical and biotechnology companies, industrial manufacturers, academic and government laboratories, and organizations involved in food, environmental and clinical testing.

The company’s product portfolio includes high-performance liquid chromatography and ultra-performance liquid chromatography systems, mass spectrometers, chromatography columns and consumables, and laboratory software for data management and analysis.